Get the Stockscreener App
9.65
3.65%
0.34
Kala Bio Inc stock is traded at $9.65, with a volume of 118.86K.
It is up +3.65% in the last 24 hours and up +19.28% over the past month.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
See More
Previous Close:
$9.31
Open:
$9.24
24h Volume:
118.86K
Relative Volume:
1.02
Market Cap:
$67.75M
Revenue:
$5.75M
Net Income/Loss:
$-38.96M
P/E Ratio:
-0.7739
EPS:
-12.47
Net Cash Flow:
$-32.63M
1W Performance:
+15.71%
1M Performance:
+19.28%
6M Performance:
+38.45%
1Y Performance:
+59.24%
1-Day Range:
$9.24
$9.68
1-Week Range:
$7.93
$9.68
52-Week Range:
$2.92
$11.20
Kala Bio Inc Stock (KALA) Company Profile
Name
Kala Bio Inc
Sector
Industry
Phone
781-996-5252
Address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Compare KALA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
9.65 | 65.37M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-11-25 | Initiated | Ladenburg Thalmann | Buy |
| Mar-30-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-14-20 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-20 | Initiated | Northland Capital | Outperform |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| May-27-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-17-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-14-19 | Initiated | Jefferies | Buy |
View All
Kala Bio Inc Stock (KALA) Latest News
Sector ETF performance correlation with KALA BIO Inc.2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser
Smart tools for monitoring KALA BIO Inc.’s price actionJuly 2025 Short Interest & Weekly Chart Analysis and Guides - Newser
What MACD signals say about KALA BIO Inc.Portfolio Update Report & Reliable Price Breakout Alerts - Newser
How to build a dashboard for KALA BIO Inc. stockCPI Data & Proven Capital Preservation Methods - Newser
Using data tools to time your KALA BIO Inc. exitGlobal Markets & Short-Term High Return Ideas - Newser
KALA BIO Inc.’s volatility index tracking explained2025 Short Interest & Target Return Focused Stock Picks - Newser
Signal strength of KALA BIO Inc. stock in tech scannersJobs Report & Precise Swing Trade Alerts - Newser
Relative strength of KALA BIO Inc. in sector analysisMarket Risk Report & Real-Time Volume Trigger Notifications - Newser
5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025 - RTTNews
What’s next for KALA BIO Inc. stock price2025 Trading Recap & Real-Time Chart Breakout Alerts - Newser
Statistical indicators supporting KALA BIO Inc.’s strengthJuly 2025 PreEarnings & Low Risk High Reward Ideas - Newser
Multi asset correlation models including KALA BIO Inc.Weekly Gains Summary & Technical Entry and Exit Tips - Newser
Will KALA BIO Inc. continue its uptrendTreasury Yields & Advanced Swing Trade Entry Alerts - Newser
Tools to monitor KALA BIO Inc. recovery probabilityEarnings Beat & Risk Managed Investment Entry Signals - Newser
Using Python tools to backtest KALA BIO Inc. strategiesIndex Update & Consistent Growth Equity Picks - Newser
What candlestick patterns are forming on KALA BIO Inc.Day Trade & Fast Momentum Entry Tips - Newser
What makes KALA BIO Inc. stock price move sharplyVolume Spike & Real-Time Price Movement Reports - Newser
Can you recover from losses in KALA BIO Inc.2025 Top Gainers & Community Verified Swing Trade Signals - Newser
Published on: 2025-08-23 22:26:04 - 더경남뉴스
Can KALA BIO Inc. weather a recession2025 Technical Overview & Weekly Momentum Picks - 더경남뉴스
5 Healthcare Stocks On Fire This Week - inkl
KALA BIO Inc. Recovery Gathers Momentum on Chart SignalsJuly 2025 Institutional & Expert Curated Trade Setups - thegnnews.com
Price momentum metrics for KALA BIO Inc. explainedWeekly Market Summary & Long-Term Growth Stock Strategies - Newser
Can KALA BIO Inc. recover in the next quarter2025 Fundamental Recap & AI Based Buy and Sell Signals - Newser
Kala Bio Inc Stock (KALA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):